Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in the nutritional and pharmacological management of phenylketonuria.

Current opinion in clinical nutrition and metabolic care - 1 Jan 2014

Ney Denise M, Blank Robert D, Hansen Karen E

Abstract excerpt

PURPOSE OF REVIEW: The purpose is to discuss advances in the nutritional and pharmacological management of phenylketonuria (PKU). RECENT FINDINGS: Glycomacropeptide (GMP), a whey protein produced during cheese production, is a low-phenylalanine (phe) intact protein that represents a new dietary alternative to synthetic amino acids for people with PKU. Skeletal fragility is a long-term complication of PKU that...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Phenylalanine Hydroxylase
Share to Biopterins
Share to Caseins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dietary Supplements

Share to Milk Proteins

Share to Phenylalanine

Share to Phenylketonurias

Share to Randomized Controlled Trials as Topic

Source

Open in PubMed Open full text

Identifiers

PMID: 24136088
DOI: 10.1097/MCO.0000000000000002
PMCID: PMC4004170

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in the nutritional and pharmacological management of phenylketonuria.PMID 24136088Read ↗

Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature ReviewSemantic proximity Read ↗

Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.Semantic proximity Read ↗

An Overview of Traditional and Novel Therapeutic Options for the Management of Phenylketonuria.Semantic proximity Read ↗

Nutritional issues in treating phenylketonuriaSemantic proximity Read ↗

Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.Semantic proximity Read ↗

Supplementation for Performance and Health in Patients with Phenylketonuria: An Exercise-Based Approach to Improving Dietary AdherenceSemantic proximity Read ↗

Recommendations for the nutrition management of phenylalanine hydroxylase deficiencySemantic proximity Read ↗

Risk factors for developing mineral bone disease in phenylketonuric patients.Semantic proximity Read ↗

The time has come: a new scene for PKU treatment.Semantic proximity Read ↗

What we know that could influence future treatment of phenylketonuria.Semantic proximity Read ↗

Comparative Analysis of Dietary Patterns in Children With Phenylketonuria Phenotypes and Controls: Implications for Nutritional Status.Semantic proximity Read ↗

New protein structures provide an updated understanding of phenylketonuria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.